Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Johnson & Johnson (J&J) has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of J&J, to prevent COVID-19 in...

The US Food and Drug Administration (FDA) has issued guidances and revised previously published guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential...

Merck & Co. has agreed to acquire Pandion Therapeutics, a Watertown, Massachusetts-based company developing therapeutics for autoimmune diseases, for an approximate total equity value of $1.85 billion. Pandion is advancing a pipeline of...

Bristol-Myers Squibb (BMS) has announced that construction is underway for a new cell-therapy manufacturing facility at its biomanufacturing site in Devens, Massachusetts. The new cell-therapy facility will be located on BMS’s current 89-acre...